Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study
Name:
ConquerFear_Baseline_paper_R1_ ...
Size:
304.1Kb
Format:
PDF
Description:
Final Accepted Manuscript
Author
Smith, Allan 'Ben'Sharpe, Louise
Thewes, Belinda
Turner, Jane
Gilchrist, Jemma
Fardell, Joanna E
Girgis, Afaf
Tesson, Stephanie
Descallar, Joseph
Bell, Melanie L
Beith, Jane
Butow, Phyllis
Affiliation
Univ Arizona, Epidemiol & BiostatIssue Date
2018-06-07Keywords
CancerFear of cancer recurrence
Metacognitions
Post-traumatic stress
Supportive care
Survivorship
Metadata
Show full item recordPublisher
SPRINGERCitation
Smith, A.., Sharpe, L., Thewes, B. et al. Support Care Cancer (2018) 26: 4207. https://doi.org/10.1007/s00520-018-4294-yJournal
SUPPORTIVE CARE IN CANCERRights
© Springer-Verlag GmbH Germany, part of Springer Nature 2018.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Despite the prevalence of fear of cancer recurrence (FCR), understanding of factors underlying clinically significant FCR is limited. This study examined factors associated with greater FCR morbidity, according to a cognitive processing model, in cancer survivors who screened positively for clinically significant FCR seeking psychological treatment through the ConquerFear trial. Participants had completed treatment for breast, colorectal or melanoma cancer 2 months to 5 years previously and scored ≥ 13/36 on the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF). Hierarchical regression analyses examined associations between demographic, medical and psychological variables, namely metacognitions (MCQ-30), post-traumatic stress symptoms (IES-R) and FCR (FCRI total score). Two hundred and ten (95%) of the 222 cancer survivors who consented to the ConquerFear trial completed the baseline questionnaire. Participants were predominantly (89%) breast cancer survivors. The final regression model accounted for 68% of the variance in FCR (demographic and medical variables 13%, metacognitions 26%, post-traumatic stress symptoms 28%). Negative metacognitive beliefs about worry and intrusive post-traumatic stress symptoms were significant individual correlates of FCR, but negative beliefs about worry did not significantly moderate the impact of intrusions on FCR morbidity. Results provide partial support for the cognitive processing model of FCR. Psychological factors were found to play an important role in FCR morbidity after controlling for demographic/medical factors. More intrusive thoughts and negative beliefs about worry were strong independent predictors of FCR morbidity. Cancer survivors with clinically significant FCR may benefit from assessment for intrusive thoughts and metacognitions and delivery of trauma- and/or metacognitive-based interventions accordingly.Note
12 month embargo; published 7 June 2018ISSN
1433-7339PubMed ID
29882025Version
Final accepted manuscriptSponsors
beyondblue; National Breast Cancer Foundation; Cancer Australia; Cancer Institute NSWgrant; NHMRCae974a485f413a2113503eed53cd6c53
10.1007/s00520-018-4294-y
Scopus Count
Collections
Related articles
- Psychological intervention (ConquerFear) for treating fear of cancer recurrence: mediators and moderators of treatment efficacy.
- Authors: Sharpe L, Turner J, Fardell JE, Thewes B, Smith AB, Gilchrist J, Beith J, Girgis A, Tesson S, Day S, Grunewald K, Butow P, ConquerFear Authorship group
- Issue date: 2019 Oct
- Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence.
- Authors: Butow PN, Turner J, Gilchrist J, Sharpe L, Smith AB, Fardell JE, Tesson S, O'Connell R, Girgis A, Gebski VJ, Asher R, Mihalopoulos C, Bell ML, Zola KG, Beith J, Thewes B
- Issue date: 2017 Dec 20
- ConquerFear-Group: A randomized controlled trial of an online-delivered group-based psychological intervention for fear of cancer recurrence in breast cancer survivors.
- Authors: Tauber NM, O'Toole MS, Jensen AB, Butow PN, Thewes B, Elkjaer E, Knutzen S, von Heymann A, Johansen C, Zachariae R
- Issue date: 2023 Sep
- Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors.
- Authors: Thewes B, Bell ML, Butow P
- Issue date: 2013 Sep
- Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence.
- Authors: Fardell JE, Jones G, Smith AB, Lebel S, Thewes B, Costa D, Tiller K, Simard S, Feldstain A, Beattie S, McCallum M, Conquer Fear authorship group, Butow P
- Issue date: 2018 Feb